Gireesh Babu, New Delhi Friday, March 13, 2026, 08:00 Hrs [IST] ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes (PAC) for recombinant DNA (r-DNA) products must now ...

A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...

CDSCO switches application procedure for PAC in marketing authorisation on r-DNA products online: Gireesh Babu, New Delhi Wednesday, March 11, 2026, 08:00 Hrs [IST] The Central Dr ...

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

Our animal-origin free recombinant proteins and enzymes portfolio, developed with Dyadic, augments Fermbox’s strategy ...

Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and biomanufacturing capabilities, Recombinant DNase I (RNase-free) is currently ...

Gene therapy offers significant opportunities globally due to its potential in treating genetic disorders. Current strategies involve modified viral vectors for gene delivery, with applications in ...

Mosquitoes are major vectors of pathogens causing diseases such as dengue, malaria, and Japanese encephalitis, imposing significant global public health and economic burdens. Traditional morphological ...

PANGYO, South Korea--(BUSINESS WIRE)--Huonslab, a subsidiary of Huons Global (KOSDAQ:084110), has submitted a Biologics License Application (BLA) to the Ministry of Food and Drug Safety for its ...